Guillain-Barré Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection

Rodino, 2020, Evaluation of saline, phosphate buffered saline and minimum essential medium as potential alternatives to viral transport media for SARS-CoV-2 testing, J Clin Microbiol, 58, e00590-20, 10.1128/JCM.00590-20

Zhao, 2020, Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?, Lancet Neurol, 19, 383, 10.1016/S1474-4422(20)30109-5

Toscano, 2020, Guillain-Barré syndrome associated with SARS-CoV-2, N Engl J Med, 10.1056/NEJMc2009191

Sedaghat, 2020, Guillain Barre syndrome associated with COVID-19 infection: a case report, J Clin Neurosci, 76, 233, 10.1016/j.jocn.2020.04.062

Padroni, 2020, Guillain-Barré syndrome following COVID-19: new infection, old complication?, J Neurol

Gutierrez-Ortiz, 2020, Miller Fisher syndrome and polyneuritis cranialis in COVID-19, Neurology, 10.1212/WNL.0000000000009619

Alberti, 2020, Guillain-Barré syndrome related to COVID-19 infection, Neurol Neuroimmunol Neuroinflamm, 7, e741, 10.1212/NXI.0000000000000741

El Otmani, 2020, Covid-19 and Guillain-Barré syndrome: more than a coincidence!, Rev Neurol (Paris), 176, 518, 10.1016/j.neurol.2020.04.007

Scheidl, 2020, Guillain-Barré syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature, J Peripher Nerv Syst, 10.1111/jns.12382

Parra, 2016, Guillain-Barré syndrome associated with Zika virus infection in Colombia, N Engl J Med, 375, 1513, 10.1056/NEJMoa1605564

Cao-Lormeau, 2016, Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study, Lancet, 387, 1531, 10.1016/S0140-6736(16)00562-6

Wijdicks, 2017, Guillain-Barré syndrome, Mayo Clin Proc, 92, 467, 10.1016/j.mayocp.2016.12.002

Sethuraman, 2020, Interpreting diagnostic tests for SARS-CoV-2, JAMA, 323, 2249, 10.1001/jama.2020.8259